BMRN
Price
$80.91
Change
-$1.26 (-1.53%)
Updated
Apr 26, 6:59 PM EST
94 days until earnings call
FOLD
Price
$10.28
Change
+$0.11 (+1.08%)
Updated
Apr 26, 6:59 PM EST
10 days until earnings call
Ad is loading...

Compare trend and price BMRN vs FOLD

Header iconBMRN vs FOLD Comparison
Open Charts BMRN vs FOLDBanner chart's image
BioMarin Pharmaceutical
Price$80.91
Change-$1.26 (-1.53%)
Volume$1.32M
CapitalizationN/A
Amicus Therapeutics
Price$10.28
Change+$0.11 (+1.08%)
Volume$1.01M
CapitalizationN/A
View a ticker or compare two or three
BMRN vs FOLD Comparison Chart

Loading...

BMRNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
FOLDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BMRN vs. FOLD commentary
Apr 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Hold and FOLD is a Sell.

COMPARISON
Comparison
Apr 28, 2024
Stock price -- (BMRN: $80.91 vs. FOLD: $10.28)
Brand notoriety: BMRN and FOLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 145% vs. FOLD: 56%
Market capitalization -- BMRN: $15.35B vs. FOLD: $3.04B
BMRN [@Biotechnology] is valued at $15.35B. FOLD’s [@Biotechnology] market capitalization is $3.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $556.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileFOLD’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • FOLD’s FA Score: 0 green, 5 red.
According to our system of comparison, BMRN is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 6 TA indicator(s) are bullish while FOLD’s TA Score has 4 bullish TA indicator(s).

  • BMRN’s TA Score: 6 bullish, 4 bearish.
  • FOLD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than FOLD.

Price Growth

BMRN (@Biotechnology) experienced а -8.71% price change this week, while FOLD (@Biotechnology) price change was -3.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.69%. For the same industry, the average monthly price growth was -8.16%, and the average quarterly price growth was +1262.42%.

Reported Earning Dates

BMRN is expected to report earnings on Jul 30, 2024.

FOLD is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (+1.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BMRN with price predictions.
OPEN
A.I.dvisor published
a Summary for FOLD with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BMRN($15.4B) has a higher market cap than FOLD($3.05B). BMRN YTD gains are higher at: -16.086 vs. FOLD (-27.555).
BMRNFOLDBMRN / FOLD
Capitalization15.4B3.05B506%
EBITDAN/AN/A-
Gain YTD-16.086-27.55558%
P/E Ratio76.33N/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
BMRN vs FOLD: Fundamental Ratings
BMRN
FOLD
OUTLOOK RATING
1..100
5861
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8698
PRICE GROWTH RATING
1..100
6377
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FOLD's Valuation (77) in the Biotechnology industry is in the same range as BMRN (82). This means that FOLD’s stock grew similarly to BMRN’s over the last 12 months.

FOLD's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BMRN (100). This means that FOLD’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's SMR Rating (86) in the Biotechnology industry is in the same range as FOLD (98). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

BMRN's Price Growth Rating (63) in the Biotechnology industry is in the same range as FOLD (77). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

BMRN's P/E Growth Rating (96) in the Biotechnology industry is in the same range as FOLD (100). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNFOLD
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 5 days ago
62%
Bullish Trend 6 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 3 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
BMRNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
FOLDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ERO20.621.54
+8.07%
Ero Copper Corp
ALLO2.890.04
+1.23%
Allogene Therapeutics
ELTX8.99-0.11
-1.21%
Elicio Therapeutics
CLF17.88-0.35
-1.92%
Cleveland-Cliffs
GWAV0.07N/A
-3.47%
Greenwave Technology Solutions

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with SRPT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-1.53%
SRPT - BMRN
45%
Loosely correlated
+1.08%
FOLD - BMRN
43%
Loosely correlated
+1.08%
AXON - BMRN
42%
Loosely correlated
+0.65%
FGEN - BMRN
41%
Loosely correlated
+1.96%
NTLA - BMRN
39%
Loosely correlated
+3.70%
More

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with MLYS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then MLYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
+1.08%
MLYS - FOLD
52%
Loosely correlated
+7.52%
NTLA - FOLD
51%
Loosely correlated
+3.70%
BEAM - FOLD
50%
Loosely correlated
-1.02%
PCVX - FOLD
47%
Loosely correlated
+1.10%
DNLI - FOLD
47%
Loosely correlated
+3.14%
More